# FDA 483 - Aurobindo Pharma Limited - January 28, 2026

Source: https://www.globalkeysolutions.net/records/483/aurobindo-pharma-limited/4402f9cb-7684-4577-a119-d85aa7d6b1c3

> FDA 483 for Aurobindo Pharma Limited on January 28, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aurobindo Pharma Limited
- Inspection Date: 2026-01-28
- Product Type: drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [483 - 2022-05-10](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-limited/32976071-2001-4f14-887c-76d96e0a30e8)

## Related Officers

- [Pratik S. Upadhyay](https://www.globalkeysolutions.net/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [Nibin Varghese](https://www.globalkeysolutions.net/people/nibin-varghese/43e17f63-2c1f-4d46-b26f-dc8ac8885438)
- [Investigator](https://www.globalkeysolutions.net/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)

Company: https://www.globalkeysolutions.net/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8